BlockRx
BlockRx
Token: BKRx


The Pharmaceutical Blockchain of Value

ICO dates
Start date: 2017-09-21
End date: 2018-01-31

Registrated in: USA

PREMIUM ICO

https://www.blockrx.com Screenshot
BlockRx categories
Cryptocurrency Health
Video
BlockRx token sale
KYC passing required No | Whitelist No | Restriction for countries No
Token distribution in ICO
40%
40%
Price 1 ETH = 130 BKRx
Minimal investment 100 USD
Acceppting BTC, ETH, LTC, Fiat
BlockRx news, social
BlockRx search trends in Google

BlockRx Roadmap

1
2014
Sponsorship by GPMS. Incorporation
2
2015
Creation of the iSolce Platform Marketplace for Biotech IP. Partnership with Tech Transfer Office at University of South Dakota.
3
2016
Creation of the BlockRx project. Partnerships. Development of ADLT.
4
2017
Partnerships (Intel, YourEncore). BlockRx token offering. Pharma Co acquiring tokens. Live pharma use case. BlockRx token integration. Resource aquisition.
5
2018
Pharma ecosystem initiation. BlockRx patient application. Resource acquisition. Product development. Expand sales and marketing
Gordon Tampol
Gordon Tampol Chief Executive Officer

Darryl G Glover
Darryl G Glover Chief Clinical Officer

Kasia Piskorska
Kasia Piskorska Chief Financial Officer

Carlos Sanchez
Carlos Sanchez Chief Technology Officer

Ryan Scott
Ryan Scott Investor Alignment and Strategy

Robert Panetta
Advisors Robert Panetta Director of Pharmaceutical Solutions

Reid Graves
Advisors Reid Graves Director of Supply Chain Solution

Jacques Vandewiele
Advisors Jacques Vandewiele IT Architect

Jan Hermans
Advisors Jan Hermans Digital Asset PM

Maria Palombini
Advisors Maria Palombini Director of Public Relations

Isaac Marks
Advisors Isaac Marks Digital Asset Manager - Outreach

Bryan Myint
Advisors Bryan Myint Manager - Digital Asset Planning

Saba Nisar
Advisors Saba Nisar Digital Marketing Analyst

Valere Dussaux
Advisors Valere Dussaux Intel Global Pharma Lead

David Houlding
Advisors David Houlding Intel Healthcare Security

Mike Lewis
Advisors Mike Lewis YourEncore Chief Revenue Officer

Daan Chen
Advisors Daan Chen Director of Pharma Solutions - Asia

Gary Ross
Advisors Gary Ross Lead Counsel

Waleed Salha
Advisors Waleed Salha Middle East Outreach

Syed Hashmi
Advisors Syed Hashmi Middle East Outreach

Jason French
Advisors Jason French Korea Outreach

Oojin Tejung
Advisors Oojin Tejung Mudgett China Outreach

Jason French
Jason French
Korea Outreach
VICE PRESIDENT
Gary Ross
Gary Ross
Lead Counsel
Legal Counsel
Legal Counsel
Advisor
Ryan Scott
Ryan Scott
Investor Alignment and Strategy
Entrepreneur, Investor, Philanthropist
Entrepreneur, social impact investor, humanist, philanthropist and online marketing pioneer, legendary for developing and patenting the double opt-in email methodology. After selling NetCreations in 2
Founder and CEO